tiprankstipranks
Trending News
More News >
Raffles Medical Group Ltd (SG:BSL)
SGX:BSL
Singapore Market
Advertisement

Raffles Medical Group (BSL) Ratios

Compare
91 Followers

Raffles Medical Group Ratios

SG:BSL's free cash flow for Q2 2024 was S$0.45. For the 2024 fiscal year, SG:BSL's free cash flow was decreased by S$ and operating cash flow was S$0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.35 1.28 1.41 1.05 1.18
Quick Ratio
1.32 1.24 1.37 1.02 1.13
Cash Ratio
0.90 0.91 0.78 0.64 0.73
Solvency Ratio
0.11 0.24 0.39 0.22 0.21
Operating Cash Flow Ratio
0.09 0.50 0.60 0.38 0.48
Short-Term Operating Cash Flow Coverage
5.03 10.67 20.30 1.66 4.46
Net Current Asset Value
S$ 50.51MS$ 319.00KS$ -7.04MS$ -129.57MS$ -158.61M
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.08 0.06 0.13 0.15
Debt-to-Equity Ratio
0.08 0.12 0.09 0.21 0.23
Debt-to-Capital Ratio
0.08 0.11 0.09 0.17 0.19
Long-Term Debt-to-Capital Ratio
0.04 0.06 0.06 0.08 0.16
Financial Leverage Ratio
1.46 1.49 1.48 1.61 1.56
Debt Service Coverage Ratio
4.74 4.39 11.35 1.26 3.01
Interest Coverage Ratio
13.05 19.04 28.46 19.09 17.16
Debt to Market Cap
0.03 0.04 0.03 0.07 0.11
Interest Debt Per Share
0.05 0.07 0.06 0.11 0.11
Net Debt to EBITDA
-4.26 -1.65 -0.67 -0.41 0.01
Profitability Margins
Gross Profit Margin
44.92%44.62%83.49%80.21%76.10%
EBIT Margin
11.29%15.28%25.67%16.85%15.77%
EBITDA Margin
16.41%18.77%30.77%22.28%22.01%
Operating Profit Margin
11.29%16.35%25.55%16.76%15.57%
Pretax Profit Margin
11.87%16.87%25.01%15.97%14.86%
Net Profit Margin
8.38%12.73%18.68%11.63%11.60%
Continuous Operations Profit Margin
8.46%12.87%18.71%11.57%11.38%
Net Income Per EBT
70.59%75.48%74.71%72.82%78.03%
EBT Per EBIT
105.17%103.18%97.89%95.28%95.47%
Return on Assets (ROA)
2.00%5.90%9.56%5.45%4.69%
Return on Equity (ROE)
2.98%8.77%14.11%8.76%7.33%
Return on Capital Employed (ROCE)
3.59%10.08%16.71%10.75%7.87%
Return on Invested Capital (ROIC)
2.52%7.50%12.32%7.11%5.81%
Return on Tangible Assets
2.02%5.97%9.69%5.56%4.81%
Earnings Yield
1.59%4.45%5.51%3.29%3.60%
Efficiency Ratios
Receivables Turnover
0.00 12.72 3.36 4.50 5.01
Payables Turnover
0.92 1.88 0.80 0.64 0.82
Inventory Turnover
18.72 31.46 9.66 10.71 9.31
Fixed Asset Turnover
0.49 0.92 1.04 0.91 0.77
Asset Turnover
0.24 0.46 0.51 0.47 0.40
Working Capital Turnover Ratio
3.43 5.90 9.76 19.64 14.52
Cash Conversion Cycle
-376.43 -154.23 -307.07 -451.20 -334.52
Days of Sales Outstanding
0.00 28.69 108.63 81.06 72.86
Days of Inventory Outstanding
19.50 11.60 37.78 34.07 39.21
Days of Payables Outstanding
395.93 194.52 453.47 566.33 446.60
Operating Cycle
19.50 40.29 146.40 115.13 112.08
Cash Flow Ratios
Operating Cash Flow Per Share
0.02 0.10 0.11 0.09 0.07
Free Cash Flow Per Share
0.01 0.09 0.09 0.06 0.04
CapEx Per Share
<0.01 0.01 0.01 0.03 0.03
Free Cash Flow to Operating Cash Flow
0.66 0.89 0.87 0.67 0.52
Dividend Paid and CapEx Coverage Ratio
0.61 2.08 2.54 1.77 1.61
Capital Expenditure Coverage Ratio
2.96 9.22 7.76 3.03 2.10
Operating Cash Flow Coverage Ratio
0.39 1.52 2.04 0.81 0.65
Operating Cash Flow to Sales Ratio
0.09 0.27 0.26 0.22 0.23
Free Cash Flow Yield
1.21%8.33%6.57%4.19%3.81%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
62.97 22.48 18.16 30.40 27.77
Price-to-Sales (P/S) Ratio
5.16 2.86 3.39 3.53 3.22
Price-to-Book (P/B) Ratio
1.84 1.97 2.56 2.66 2.04
Price-to-Free Cash Flow (P/FCF) Ratio
82.49 12.01 15.21 23.86 26.26
Price-to-Operating Cash Flow Ratio
55.82 10.71 13.25 15.98 13.74
Price-to-Earnings Growth (PEG) Ratio
-3.21 -0.60 0.25 1.17 3.55
Price-to-Fair Value
1.84 1.97 2.56 2.66 2.04
Enterprise Value Multiple
27.21 13.60 10.36 15.45 14.64
Enterprise Value
1.63B 1.81B 2.44B 2.49B 1.83B
EV to EBITDA
27.21 13.60 10.36 15.45 14.64
EV to Sales
4.46 2.55 3.19 3.44 3.22
EV to Free Cash Flow
71.32 10.71 14.29 23.23 26.29
EV to Operating Cash Flow
47.23 9.55 12.45 15.56 13.76
Tangible Book Value Per Share
0.55 0.55 0.54 0.51 0.48
Shareholders’ Equity Per Share
0.55 0.55 0.55 0.51 0.49
Tax and Other Ratios
Effective Tax Rate
0.29 0.24 0.25 0.28 0.23
Revenue Per Share
0.19 0.38 0.41 0.39 0.31
Net Income Per Share
0.02 0.05 0.08 0.05 0.04
Tax Burden
0.71 0.75 0.75 0.73 0.78
Interest Burden
1.05 1.10 0.97 0.95 0.94
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.13 2.10 1.37 1.91 2.06
Currency in SGD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis